Bloomage Biotech 2022 Financial Report
Bloomage Biotech reports 28.53% YoY revenue increase, reaches $927.8 million in 2022
12 avr. 2023 09h00 HE | Bloomage BioTechnology Corporation Limited
Parsippany, New Jersey, USA, April 12, 2023 (GLOBE NEWSWIRE) -- Bloomage Biotech (688363.SH) released its 2022 Financial Report on March 30, 2023, posting a revenue of $924 million, an increase of...
Lumenis M22 medical wound dressing
Bloomage Biotech and Lumenis release postoperative care product to accelerate laser skin treatment recovery
16 mars 2023 09h00 HE | Bloomage BioTechnology Corporation Limited
Parsippany, New Jersey, USA, March 16, 2023 (GLOBE NEWSWIRE) -- Bloomage Biotech, a leader in sodium hyaluronate products, and Lumenis, a pioneering medical laser equipment provider, have...
Bloomage Biotech has been awarded the prestigious Fountain Awards
Bloomage Biotech receives the PCHi2023 Fountain Awards for innovation exellence
06 mars 2023 10h01 HE | Bloomage BioTechnology Corporation Limited
Parsippany, New Jersey, USA, March 06, 2023 (GLOBE NEWSWIRE) -- Bloomage Biotech has been awarded the prestigious Fountain Awards at the Asia-Pacific international event, PCHi, held in Guangzhou...